Margie Castillo-melendez PhD

Dr. Margie Castillo-Melendez, PhD, is a neuroscientist and a senior member of the fetal and neonatal Research Group at the Ritchie Centre. She has also undertaken an Overseas Study Program worked (in an honorary capacity) at the Neurovascular Research Unit (UIN), located at the Department of Pharmacology of the Universidad Complutense School of Medicine, in Madrid, Spain with a research group coordinated by Professors Ignacio Lizasoain and María Ángeles Moro, who are leading experts in the field of cerebral ischemia and stroke.

Over the past 15 years, she has been involved in the investigation of various novel therapeutic neuroprotective agents in adult stroke and fetal and neonatal hypoxia/asphyxia. She’s currently involved in projects investigating the effects of hypoxia/asphyxia on fetal brain injury and repair researching potential therapeutic strategies to protect the fetal brain from intrauterine hypoxia/asphyxia, in particular prophylactic maternal treatment with creatine and melatonin and rescue therapy with umbilical cord-derived cells.

She has extensive experience in small and large animal models of chronic and acute hypoxia. Dr Castillo-Melendez is an expert in the field on neurovascular research and has published several neuroscience papers in journals ranked near the top for the discipline.